- Prophylactic therapy using epigenetic agents for RUNX1::RUNXT1-positive high-risk AML after Allo-HSCT
Wenwen Guo et al, 2024, Annals of Hematology CrossRef - Simvastatin prevents BMP-2 driven cell migration and invasion by suppressing oncogenic DNMT1 expression in breast cancer cells
Pooja Yadav et al, 2023, Gene CrossRef - DNA Methylation Alterations in Acute Myeloid Leukemia: Therapeutic Potential
Aysun Adan, 2023, CrossRef - Research Progress of Epigenetic Therapy in Acute Myeloid Leukemia
香会 杨, 2022, Advances in Clinical Medicine CrossRef - Ribonucleotide reductase M2 (RRM2): Regulation, function and targeting strategy in human cancer
Zanwen Zuo et al, 2024, Genes & Diseases CrossRef - Chidamide: Targeting epigenetic regulation in the treatment of hematological malignancy
Han‐Yu Cao et al, 2023, Hematological Oncology CrossRef - Chidamide induces cell cycle arrest via NR4A3/P21 axis upregulation to suppress relapsed and refractory acute myeloid leukemia
Xuefeng Feng et al, 2024, Biochemical and Biophysical Research Communications CrossRef - Efficacy and safety of an HDACi- and HMA-based protocol in adults with acute myeloid leukemia of intermediate- and adverse-risk categories: a retrospective study
Zhibo Guo et al, 2023, Hematology CrossRef - Application of prophylactic or pre-emptive therapy after allogeneic transplantation for high-risk patients with t(8;21) acute myeloid leukemia
Wenwen Guo et al, 2023, Hematology CrossRef